| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K66532283 |
| PharmacoGx | BRD-K66532283 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZNF84 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | GANAB | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | HPR | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | LAX1 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | ARL16 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | ADAM9 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.02 |
| mRNA | CTD-2545G14.7 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | RASL10B | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | OR8B3 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | RP4-635E18.9 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
